Mylan’s generic to cost 70% less then Advair 12-Feb-2019 By Maggie Lynch Mylan’s recently FDA-approved Advair Diskus generic to be offered at 70% cost reduction to its reference drug, and 67% less than GSK’s generic version.
First generic to Advair is approved after long wait 31-Jan-2019 By Ben Hargreaves GSK’s luck at maintaining sales on its off-patent Advair product has run out, with Mylan’s generic version receiving approval from the US FDA.
GSK breathes easy on Advair generic delay, earnings boosted by 3% 25-Jul-2018 By Ben Hargreaves Though generic competition to Advair is still on the horizon, GSK’s Q2 financials revealed the importance of its rivals’ delays.
